Evidence Synthesis
KAYNES Sees Continued Growth Momentum, with Revenue Growth Yoy Accelerating to 40.5%, and Gross Margin Accelerating to 33.4%.
The company's Daily Volume and DAILY_VOLUME accelerated to , while its Close Price Decelerated to .
Evidence Synthesis
Last synthesized: 25 Aug 2026, 03:34
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
KAYNES Sees Continued Growth Momentum, with Revenue Growth Yoy Accelerating to 40.5%, and Gross Margin Accelerating to 33.4%.
The company's Daily Volume and DAILY_VOLUME accelerated to , while its Close Price Decelerated to .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 33.4 % | 11.69 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 11.69 % | 8.87 | ▲ |
| REVENUE_GROWTH_YOY | 40.5 % | -0.4 | ▲ |
| EPS_ACTUAL | 18.5 INR | 11.444 | ▲ |
| EPS_SURPRISE_PERCENT | 0.265 % | -0.368 | ▲ |
| PRICE_CHANGE_PERCENT | -1.28 % | — | - |
| DAILY_VOLUME | 12,51,147 shares | 12,41,783 | ▲ |
| CLOSE_PRICE | 3,840.2 INR | 3,890 | ▼ |
| NEWS_SENTIMENT_SCORE | -0.17 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 3 count | 2 | ▲ |
| TARGET_PRICE_PREMIUM | -3.25 % | — | - |